Anwita Biosciences, Inc. is an emerging biopharmaceutical company headquartered in the San Francisco Bay Area.
Our mission is to deliver transformative treatment options to improve the lives of patients with cancer and autoimmune diseases. We specialize in the discovery and development of optimized immunotherapeutics, leveraging our core expertise in cancer immunotherapy, bioinformatics, and structure-based protein engineering.
We are advancing our product pipeline of improved cytokines (ExenokinesTM) and tumor targeting antibody drug conjugates. Our lead product is expected to enter clinical trials in 1H 2021.
ExenokinesTM are proprietary cytokines designed using Anwita Biosciences’ patented platform technology. Our modular design enables accelerated development of a diversified portfolio of cytokine-based products with improved pharmaceutical properties.
Our scientists are developing a suite of innovative ADC technologies and payloads. The company is advancing a pipeline of tumor targeting ADCs with enhanced efficacy in vivo.
- September 30th, 2020 - Anwita Biosciences and Shanghai Junshi Biosciences entered into a new collaboration in which Junshi was granted the exclusive rights to Anwita's Exenokine-2, an improved IL-2 variant with extended half-life, in the Greater China territories. (PDF)
- June 24th, 2019 - Strategic collaboration between Anwita Biosciences and Shanghai Junshi Biosciences whereby Junshi was granted the exclusive rights to develop and commercialize Anwita's Exenokine-21 program in the Greater China territories. (PDF)
Working at Anwita
We are always seeking exceptional talent that is passionate about making a difference in the lives of patients with cancer or autoimmune disorders. If you share our mission, and are interested in joining our team, please reach out to us via email at [email protected].
- Competitive compensation
- Stock options at all levels
- 401(K) plan
- Official holidays
- Generous paid time off (PTO)
- Sick days
- Medical plan
- Dental plan
- Visional plan
- Life insurance